lobbying_activities: 2060304

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2060304	9e271216-a5c0-4f40-96ad-c85e4a8b5d35	Q4	FARRAGUT PARTNERS LLP	401103938	GENENTECH	2017	fourth_quarter	MMM	Concerns regarding Medicare payment policies for Part B drugs. Issues related to the 340B Drug discount program. Medicare Part B Demonstration. Prescription Drug User Fee Act. CHIP reauthorization.	Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE	50000		0	0	2018-01-11T13:35:12.157000-05:00